BMC Cancer

Article	Citations
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade	258
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification	149
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer	126
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy	119
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors	116
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer	95
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma	86
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections	81
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol	77
Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study	73
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer	71
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database	67
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer	67
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers	67
Rapid and label-free detection of gastrointestinal stromal tumor via a combination of two-photon microscopy and imaging analysis	66
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study	65
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and	61
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer	59
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients	58
Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics	56
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	56
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	54
Correlation between overall survival and quality of life in colon cancer patients with chemotherapy	53
NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA1	52
Realizing the promise of machine learning in precision oncology: expert perspectives on opportunities and challenges	51

Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma	50
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting	50
Unraveling the causal links and novel molecular classification of Crohn’s disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling	49
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis	49
The impact of curative cancer treatment on sexual health – clinical results from the EORTC QLQ-SH22 validation study	48
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis	47
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	47
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study	47
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer	47
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?	46
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients	46
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communic	45
Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophag	45
Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer	45
Pseudocapsule thickness is positively associated with prognosis in patients with clear cell renal cell carcinoma	44
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer	43
Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment	42
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients	42
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	42
Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study	40
Association of portfolio diet score with breast cancer risk: insights from a case-control analysis	40
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population	40
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (S	40
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer	39
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation	39
Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation	39
Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study	38
Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study	38
TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study	38
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer	38
MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts	37
Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study	37
Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma	37
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis	37
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy	37
An in-frame deletion mutation in MLH1 drives Lynch syndrome-associated colorectal cancer	37
Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership	36
Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy	36
Added value of pretreatment CT-based Node-RADS score for predicting survival outcome of locally advanced gastric cancer: compared with clinical N stage	36
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway	36
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy	36
Integration of graph neural networks and transcriptomics analysis identify key pathways and gene signature for immunotherapy response and prognosis of skin melanoma	36
Association between psychiatric disorders and glioma risk: evidence from Mendelian randomization analysis	35
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial	35
Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial	35
EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma	35
Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma	35
Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol	35
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation	35
Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study	35

Muscle strength is associated with fracture risk obtained by fracture risk assessment tool (FRAX) in women with breast cancer	34
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients	34
Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis	34
Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study	34
“It's very important that you measure throughout that journey…”: patient perspectives towards quality-of-life data collection following haematopoietic cell transplant	34
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients	34
L-arginine dependence of breast cancer – molecular subtypes matter.	34
Improved urine DNA methylation panel for early bladder cancer detection	34
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherap	33
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study	33
MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR	33
Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection	33
Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients	33
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter study	33
Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis	33
A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial	33
Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study	33
Combined inflammation-related biomarkers and clinicopathological features for the prognosis of stage II/III colorectal cancer by machine learning	33
Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study	32
The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining	32
Survival benefit of adjuvant TACE for patients with hepatocellular carcinoma and child-pugh B7 or B8 after hepatectomy	32
Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receivi	32
High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinoma	32
HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib	32
Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlle	32
Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study	32
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland	32
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study	32
Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma	31
A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer	31
Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response	31
Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor	31
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer	31
Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center	31
Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan	31
System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening	31
Deep learning-based characterization of pathological subtypes in lung invasive adenocarcinoma utilizing 18F-deoxyglucose positron emission tomography imaging	30
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study	30
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma	30
The value of diffusion kurtosis imaging and intravoxel incoherent motion quantitative parameters in predicting synchronous distant metastasis of rectal cancer	30
Whole-body CT scanning radiation improves the immune microenvironment of tumor tissues to enhance the antitumor effect of ICI	30
Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy	30
Ten-year follow-up of atypical small acinar hyperplasia cases diagnosed by initial prostate biopsy	30
Underdiagnosis of iron deficiency anemia among patients with colorectal cancer: an examination of electronic medical records	30
Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator	30
Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features	30
Sex-disaggregated analysis of breast cancer prevalence in Sierra Leone	29
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis	29
AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway	29
The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer	29
Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review	28
Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses	28
Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy	28
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study	28
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway	28
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines	28
Beta-Blockers and mortality in patients with malignancy and cardiovascular disease: an analysis of the MIMIC-IV database	27
Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions	27
Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030	27
Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production	27
microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation	27
Understanding referral of patients with cancer in rural Ethiopia: a qualitative study	27
A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC	27
Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4	27
Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells	27
Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China	27
Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis	26
Effect of intrapleural anti-Vascular Endothelial Growth Factor (VEGF) associated with nab paclitaxel in a murine model of malignant pleural effusion	26
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness	26
MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells	26
Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells	26
Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma	26
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy	26
Effectiveness of educational intervention on women’s participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model	26
Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M	26
PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis	26
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study	26
A metabolome-wide case-control study of african american breast cancer patients	26
Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study	26
Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity	26

Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, random	25
The association between organised colorectal cancer screening strategies and reduction of its related mortality: a systematic review and meta-analysis	25
Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN signaling	25
Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression	25
Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer	25
Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis	25
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review	25
Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence	25
Integrated analysis of the prognostic and oncogenic roles of OPN3 in human cancers	25
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study	25
The relationship between dairy products intake and breast cancer incidence: a meta-analysis of observational studies	25
Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines	25
Assessing the selective impact of histone modifying drugs on adenoid cystic carcinoma cells and their stem cell counterparts	25
Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark	25
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer,	25
Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study	25
Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma	25
Characterization and comparison of human glioblastoma models	25
Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: a cancer-specific exploration	24
Correction: Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer	24
TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle	24
Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer	24
The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model	24
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells	24
A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis	24
Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1	24
Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population	24
Development of a clinical-molecular prediction model for central lymph node metastasis in cN0 stage papillary thyroid microcarcinoma: a retrospective study	24
Gut microbiome and its role in colorectal cancer	24
A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer	24
Analyses of quality of life in cancer drug trials - a review of measurements and analytical choices in post-reimbursement studies	24
A clinical model to predict brain metastases in resected early-stage non-small cell lung cancer	24
Most oncological pancreas resections must consider the mesopancreas	24
A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial	23
Nomogram model for predicting the long-term prognosis of cervical cancer patients: a population-based study in Mato Grosso, Brazil	23
Dual-region MRI radiomic analysis indicates increased risk in high-risk breast lesions: bridging intratumoral and peritumoral radiomics for precision decision-making	23
Aiming for survival: a qualitative single case study of support for family members across the care process in outpatient colorectal cancer care	23
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma	23
Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis	23
Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target	23
Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC	23
Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis	23
High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas	23
Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC	23
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma	23
Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice	23
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma	23
Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study	23
Correlation analysis of DLG5 and PD-L1 expression in triple-negative breast cancer	23
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial canc	22
Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan	22
Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation	22
TOTEM: a multi-cancer detection and localization approach using circulating tumor DNA methylation markers	22
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors	22
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study	22
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgical	22
Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): a novel prognostic factor in colorectal cancer	22
Exploring educational disparities in breast cancer dynamics: a comprehensive analysis of incidence, death within 5 years of diagnosis, and mortality in the Belgian context	22
The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma	22
Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis	22
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas	22
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study	22
Nasopharyngeal carcinoma detected noninvasively in the real world using three gene methylation analyses from automatically processed bilateral nasal swab samples	22
LINC00657 exhibits oncogenic properties in prostate cancer and may serve as a prognostic biomarker in cancer	22
Preoperative IL-8 levels as prognostic indicators of overall survival: an extended follow-up in a prospective cohort with colorectal liver metastases	22
Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors	22
Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study	22
Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line	22
Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy	22
Data quality in Brazilian population-based cancer registries for gastrointestinal cancers	22
Laparoscopic versus open surgery for perihilar cholangiocarcinoma: a multicenter propensity score analysis of short- term outcomes	22
RETRACTED ARTICLE: LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells	22
Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone	22
The prognostic impact of macroscopic serosal change on resectable advanced gastric cancer	22
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers	22
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC	22
The value of preoperative RDW for post-pancreatectomy haemorrhage and surgical prognosis in patients with pancreatic cancer: a retrospective study	21
The impact of financial burden on quality of life among German head and neck cancer survivors	21
Different NGS identification methods of somatic mutation sites in solid tumors impact TMB results	21
Rectal prolapse as an initial presentation of colorectal cancer: a systematic review	21
Identifying immunohistochemical biomarkers panel for non-small cell lung cancer in optimizing treatment and forecasting efficacy	21
A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma	21
A retrospective cohort study on radio/chemotherapy and survival following esophageal fistula in esophageal cancer patients with prior radiotherapy	21
Nomogram based on autophagy related genes for predicting the survival in melanoma	21
Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis	21
Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027	21
A dosimetric comparison of brachytherapy sources for endometrial cancer: an electronic brachytherapy and an iridium-192 source with multichannel cylinders and a three-dimensional technique	21
Investigating the role of non-synonymous variant D67N of ADGRE2 in chronic myeloid leukemia	21
Cancer risk following onset of type 2 diabetes in New Zealanders with impaired glucose tolerance over 25 years: a matched prospective cohort study	21
Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer	21
Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs	21
The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015)	21
Establishment of potential lncRNA-related hub genes involved competitive endogenous RNA in lung adenocarcinoma	21
Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations	21
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer	21